Cardiome Announces Term Loan Agreement with CRG-Managed Funds
PR Newswire - Tue Jun 14, 7:00AM CDT
NASDAQ: CRME TSX: COM
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher
Zacks Equity Research - Zacks Investment Research - Mon May 23, 7:25AM CDT
Cardiome Pharma Corp. (CRME) moves big in the last session, shares jump over 8% on the day.
CRME: 5.02 (+0.07), JNP: 7.10 (+0.12)
Cardiome reports 1Q loss
Automated Insights - Fri May 13, 6:11AM CDT
VANCOUVER, British Columbia (AP) _ Cardiome Pharma Corp. (CRME) on Friday reported a loss of $1.2 million in its first quarter.
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome Reports First Quarter 2016 Financial Results
CNW Group - Fri May 13, 6:00AM CDT
Cardiome to conduct conference call and webcast today, May 13, 2016 at 8:00am Eastern (5:00am Pacific)
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome Announces the Launch of ESMOCARD Solution for Injection in France
CNW Group - Thu May 12, 7:00AM CDT
NASDAQ: CRME TSX: COM
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome Announces Publication of Spanish Emergency Department BRINAVESS Study
CNW Group - Wed May 11, 7:00AM CDT
NASDAQ: CRME TSX: COM
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome to Hold First Quarter 2016 Financial Results Conference Call on May 13
CNW Group - Wed May 11, 7:00AM CDT
NASDAQ: CRME TSX: COM
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:45AM CDT
With the Q1 cycle nearing its end, the earnings picture is becoming increasingly clear. While the going looked tough at the onset of the last month, that scenario has changed over the past few weeks.
CRME: 5.02 (+0.07), JNJ: 116.96 (+0.50), EARS: 3.96 (-0.09), GILD: 83.38 (+0.93), BITI: 25.80 (-0.71), BPTH: 2.24 (+0.10), AMGN: 152.10 (+2.29), ACRS: 18.18 (+0.11), ACOR: 26.16 (+0.89), NVS: 80.44 (+0.73)
IIROC Trade Resumption - Cardiome Pharma Corp.
Newsfile Corp - Fri May 06, 7:27AM CDT
Trading resumes in:
CRME: 5.02 (+0.07)
IIROC Trade Halt - Cardiome Pharma Corp.
Newsfile Corp - Thu May 05, 3:19PM CDT
The following issues have been halted by IIROC:
CRME: 5.02 (+0.07)
Cardiome and Allergan Announce XYDALBA™ (Dalbavancin) Licensing Agreement in International Markets
PR Newswire - Thu May 05, 3:15PM CDT
NASDAQ: CRME TSX: COM
AGN: 229.96 (+1.41), CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome and Allergan Announce XYDALBA(TM) (Dalbavancin) Licensing Agreement in International Markets
CNW Group - Thu May 05, 3:15PM CDT
NASDAQ: CRME TSX: COM
AGN: 229.96 (+1.41), CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
Cardiome to Present at the Bloom Burton & Co. 5th Annual Healthcare Investor Conference
PR Newswire - Thu Apr 28, 7:00AM CDT
NASDAQ: CRME TSX: COM
CRME: 5.02 (+0.07), COM.TO: 6.40 (+0.05)
New Strong Sell Stocks for April 25th
Zacks Equity Research - Zacks Investment Research - Mon Apr 25, 8:16AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
CRME: 5.02 (+0.07), ANGI: 7.64 (+0.16), AXTA: 28.63 (+0.67), ABY: 18.47 (+0.33), BRK.B: 145.22 (+1.28)